Table 6.

Adverse events reported during the study

Number of patients presenting adverse events (n, %)	Children [N = 203]	Adults [N = 280]	Total [N = 483]
Any adverse event Number of adverse events	47 (23.2%) 91	75 (26.8%) 164	122 (25.3%) 255
Adverse events related to 5GPE-SLIT Number of adverse events	36 (17.7%) 67	62 (22.1%) 140	98 (20.3%) 207
Unexpected adverse events related to 5GPE-SLIT Number of adverse events	3 (1.5%)	5 (1.8%)	8 (1.7%)
Serious adverse events related to 5GPE-SLIT Number of adverse events	2 (1.0%)	2 (0.7%)	4 (0.8%) 11
Serious and unexpected adverse events related to 5GPE-SLIT Number of adverse events	None	1 (0.4%)	1 (0.2%)

Italic represents the number of adverse events (one patient could have several dares event, and could be removed for the 3 last items (unexpected adverse events, serious adverse events, unexpected and serious adverse events)